Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. (SHA:603707)
China flag China · Delayed Price · Currency is CNY
9.67
+0.39 (4.20%)
Feb 3, 2026, 3:00 PM CST

SHA:603707 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
1,4481,0241,2101,389658.55493.55
Trading Asset Securities
1,2521,055681.991.3259.8845.79
Cash & Short-Term Investments
2,6992,0801,8921,390918.351,339
Cash Growth
38.13%9.94%36.12%51.34%-31.43%210.56%
Accounts Receivable
1,037920.04771.68974.11897.75788.11
Other Receivables
252.13273.46230.88241.94167.88107.21
Receivables
1,2891,1941,0031,2161,066895.31
Inventory
3,4043,6754,1585,6164,8944,457
Prepaid Expenses
-13.1711.988.467.9810.11
Other Current Assets
138.3184.42196.9964.1443.6265.9
Total Current Assets
7,5307,0467,2628,2946,9306,768
Property, Plant & Equipment
1,2111,1971,2351,198827.42532.83
Long-Term Investments
82.6583.2672.4861.626.393.26
Goodwill
128.02129.51127.61125.48114.87117.56
Other Intangible Assets
330.33337.53174.1118.96123.85105.37
Long-Term Deferred Tax Assets
165.59203.25348.4101.4734.5421.65
Long-Term Deferred Charges
806.12459.55294.2494.6277.6555.52
Other Long-Term Assets
53.1353.710.3816.3182.34116.08
Total Assets
10,3079,5109,52410,0108,2177,720
Accounts Payable
687.9495.66537.74505.12458.87502.22
Accrued Expenses
222.11207.11294.8588.1564.5647.26
Short-Term Debt
1,5081,2361,5671,9571,5712,132
Current Portion of Long-Term Debt
534.168.21505.450.42--
Current Income Taxes Payable
25.993.7229.310.448.7317.42
Current Unearned Revenue
9.5159.0335.9338.2225.0729.08
Other Current Liabilities
74.9754.67116.18115.44138.5677.65
Total Current Liabilities
3,0632,0643,0862,7052,2662,806
Long-Term Debt
322.33824.16512.37997.36480.751,132
Long-Term Leases
60.0610.2813.2315.94--
Long-Term Unearned Revenue
79.9884.6376.5784.9965.5138.15
Long-Term Deferred Tax Liabilities
31.1538.2837.3339.991.42-
Total Liabilities
3,5563,0223,7263,8432,8143,976
Common Stock
1,6161,6161,6171,6171,244934.16
Additional Paid-In Capital
587.29587.29601.02603.59987.96157.77
Retained Earnings
4,4724,2043,5403,9153,1232,485
Treasury Stock
-10.22--27.75-32.82-47.3-14.43
Comprehensive Income & Other
89.9884.6272.567.970.45159.79
Total Common Equity
6,7556,4925,8026,1715,3783,722
Minority Interest
-3.53-3.51-3.47-3.4724.8422.12
Shareholders' Equity
6,7516,4885,7986,1675,4033,745
Total Liabilities & Equity
10,3079,5109,52410,0108,2177,720
Total Debt
2,4252,0792,5982,9712,0513,264
Net Cash (Debt)
274.621.13-706.06-1,581-1,133-1,925
Net Cash Per Share
0.170.00-0.45-0.97-0.72-1.21
Filing Date Shares Outstanding
1,5911,6161,4731,6531,5431,662
Total Common Shares Outstanding
1,5911,6161,4731,6531,5431,662
Working Capital
4,4684,9814,1755,5894,6633,962
Book Value Per Share
4.254.023.943.733.492.24
Tangible Book Value
6,2966,0255,5005,9265,1393,500
Tangible Book Value Per Share
3.963.733.733.583.332.11
Buildings
-472.9481.48448.47268.49164.68
Machinery
-1,3231,279981.72751.74606.4
Construction In Progress
-137.4479.74250.62215.2699.68
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.